Timing of Last Lantus Dose Before Cardiac Surgery
Administer 75-80% of the usual Lantus dose on the evening before surgery (the night prior to the morning of your MVR/TV annuloplasty with CABG). This is the standard perioperative approach for long-acting basal insulin analogs like insulin glargine.
Recommended Dosing Strategy
Based on current perioperative diabetes management guidelines 1, the approach for basal insulin analogs before surgery is:
- Reduce the dose to 75-80% of usual when given the evening before surgery
- Timing: Evening before surgery (assuming morning surgery, which is typical for major cardiac procedures)
- This maintains basal insulin coverage while reducing hypoglycemia risk during the fasting perioperative period
The FDA labeling for Lantus 2 confirms its 24-hour duration of action with relatively constant insulin levels and no pronounced peak, which supports evening dosing the night before surgery.
Evidence-Based Rationale
The 2025 ADA Standards 1 specifically recommend for perioperative care:
- Long-acting basal insulin analogs should be reduced to 75-80% of the usual dose
- This differs from NPH insulin (which requires 50% dose reduction due to its peaked action profile)
- Target perioperative blood glucose should be 100-180 mg/dL (5.6-10.0 mmol/L)
Research supports this approach 3: A prospective randomized trial of 401 patients undergoing elective noncardiac surgery found that taking 80% of the usual evening insulin glargine dose achieved appropriate preoperative fasting blood glucose targets without excessive hypoglycemia or hyperglycemia risk.
Critical Perioperative Considerations
Do NOT hold or skip the Lantus entirely - this would leave the patient without basal insulin coverage for 24+ hours given Lantus's pharmacokinetics, risking severe hyperglycemia and potential diabetic ketoacidosis, especially in the stress of major cardiac surgery.
Other medications to address:
- Hold metformin on the day of surgery 1
- Discontinue SGLT2 inhibitors 3-4 days before surgery 1 (though recent evidence 4 suggests this may be overly conservative, the guideline recommendation remains 3-4 days for elective procedures)
- Hold other oral agents the morning of surgery 1
Monitoring Plan
- Check blood glucose in the preoperative holding area
- Expect transition to intravenous insulin infusion during the cardiac surgery itself for tight glycemic control
- Plan for subcutaneous basal insulin resumption 2-4 hours before stopping IV insulin postoperatively to prevent rebound hyperglycemia 1
The cardiac surgical stress response and cardiopulmonary bypass will significantly affect glucose metabolism 5, making intraoperative IV insulin the standard for CABG procedures, but maintaining some basal insulin effect from the preoperative dose helps bridge this transition safely.